ST. LOUIS — A Missouri judge on Friday approved Bayer’s $7.25 billion settlement of lawsuits alleging that its weedkiller Roundup causes cancer, a decision that could ultimately resolve litigation that has weighed on the company for a decade, according to Reuters.
The nationwide settlement applies both to Roundup users who are already ill and to people who are diagnosed with non-Hodgkin lymphoma in future years, according to the Associated Press. Participants could receive between $10,000 and $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness. Read the AP report here.
St. Louis Circuit Judge Timothy Boyer found the settlement fair, reasonable and adequate, and said the average individual payouts are fair and adequate. He described the total as among the largest in the history of mass tort personal injury class action settlements. The approved settlement includes $600 million for attorneys’ fees.
To fund the settlement, Monsanto, the Bayer unit that makes Roundup, will make declining capped annual payments for up to 21 years totaling up to $7.25 billion, including payments already made, the company said. The settlement covers people who allege they were exposed to Roundup before February 17, 2026, including those already diagnosed and those diagnosed during a 16 year period after final approval. Bayer’s own statement is here.
Bayer, which is based in Germany, denies that Roundup causes cancer. It has faced thousands of claims from U.S. cancer patients who say the company should have warned people that the weedkiller could cause lymphoma. The litigation has cost the company heavily for close to a decade and led it to consider pulling the product from U.S. agricultural markets.
Judge Boyer said there was a risk Bayer would have filed for bankruptcy protection if the settlement had been rejected. Bayer Chief Executive Bill Anderson said the court approved settlement is a decisive milestone in the company’s strategy to reduce the risks of both pending and future Roundup litigation.
The approval follows a favorable Supreme Court ruling for the company in June in the Durnell case, which found that federal pesticide law preempts failure to warn cases brought in state court, and a defense verdict in the first case to go to trial since that ruling. The company described the settlement and the Supreme Court ruling as two pillars of its plan to contain the litigation.
What happens next: the final approval order can still be appealed, so the claims program is not yet beyond challenge. If it stands, it sets up a long term system, running for up to two decades, to pay current and future claims instead of fighting them case by case in court.
